Podcast 22 Sep 2023

Beyond Biotech podcast 64 – Precision immuno-oncology therapies

Flamingo Therapeutics receives €1.7M to advance RNA-targeting oncology portfolio

Gilead boosts oncology pipeline with XinThera acquisition


Eterna acquires allogeneic immuno-oncology platform from Exacis 

Sumitomo Pharma Oncology receives orphan drug designation for Ewing sarcoma treatment

Flare Therapeutics sees $123M oncology boost

Etana secures funding for oncology pipeline

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

Debiopharm adds to oncology pipeline

TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials